Private equity can transform India's healthcare, if done right

Private equity investment in India's healthcare sector surged post-COVID, attracting $5-6 billion annually, up from pre-pandemic levels of $3-4 billion. PE can transform India's healthcare, if done right.

Major global players like Blackstone, Temasek and KKR are aggressively acquiring hospital chains and medical device companies, filling critical gaps left by public healthcare underfunding. PE firms drive consolidation for scale and efficiency, but this raises important questions about maintaining patient-centered care alongside profitability.

PE capitalizes on India's healthcare boom

Rapid growth in demand, rising incomes and increased lifestyle diseases make India's market highly attractive. PE investments, initially fragmented, have shifted toward large-scale deals, notable examples include Blackstone's CARE Hospitals acquisition and Temasek's controlling stake in Manipal Hospitals.

Learning from US mistakes

The US experience warns of pitfalls, high debt, reduced quality of care, and neglect of essential services like primary care, when profit overrides patient needs. Indian policymakers and providers must proactively manage these risks. India must prioritize primary and essential care, ensure transparent patient-focused regulatory frameworks, and balance investor returns with sustainable outcomes.